Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about Eli Lilly and Co

Recent news which mentions Eli Lilly and Co

< Previous 1 2 3 4 5 6 7 8 9

...

Treasury yields retreat ahead of big week for economic data

January 22, 2024

Cramer lists his major themes for the market in 2024

January 17, 2024

The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space

January 17, 2024

Cramer cheers Monday's tech gains, but tells investors to keep a diverse portfolio with an eye towards health care

January 08, 2024

People may eat more calories after stopping weight loss drugs, according to Deutsche Bank survey

January 08, 2024

Cramer's week ahead: Earnings season kicks off after JPMorgan Healthcare Conference

January 05, 2024

Eli Lilly's direct drug sales may not upend the industry alone – but others could follow suit

January 05, 2024

Here are the big health sector themes to watch next year

December 22, 2023

10-year Treasury yield falls slightly on shorter trading day

December 22, 2023

10-year Treasury yield falls as investors continue to assess path ahead for rate cuts

December 21, 2023

Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma

December 20, 2023

Treasury yields dip slightly as Fed trajectory remains in focus

December 20, 2023

Treasury yields down slightly as recent trend continues

December 19, 2023

5 things to know before the stock market opens Monday

December 18, 2023

The weight loss drug boom isn't over yet — here's what to expect in the year ahead

December 17, 2023

Patients regain weight after stopping Eli Lilly's Zepbound, study says

December 11, 2023

Treasury yields inch higher ahead of Fed meeting

December 11, 2023

Biden administration asserts power to seize drug patents in move to slash high prices

December 07, 2023

Cramer examines Tuesday's market 'mistakes,' points out underappreciated stocks

December 05, 2023

Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages

December 05, 2023

Cramer says the growing popularity of weight loss drugs brings new investing opportunities

December 04, 2023

Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops

December 02, 2023

Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects

December 01, 2023

Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs

November 30, 2023

Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says

November 27, 2023

This key element of ESG investing could drive real change at companies and boost returns

November 18, 2023

Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members

November 13, 2023

Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success

November 13, 2023

Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index

November 10, 2023

FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug

November 08, 2023

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.